Unilocular adnexal cysts with papillary projections but no other solid components: Is there a diagnostic method that can classify them reliably as benign or malignant before surgery?

Ultrasound in Obstetrics and Gynecology

Volumn 41, Issue 5, 2013, Pages 570-581

  Valentin, L ^a   Ameye, L ^b   Savelli, L ^c   Fruscio, R ^d   Leone, F P G ^e   Czekierdowski, A ^f   Lissoni, A A ^d   Fischerova, D ^g   Guerriero, S ^h   Van Holsbeke, C ^i,j   Van Huffel, S ^b,k   Timmerman, D ^j  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^g CHARLES UNIVERSITY   (Czech Republic)

^h UNIVERSITY OF CAGLIARI   (Italy)

ⁱ DEPARTMENT OF CARDIOLOGY   (Belgium)

^j UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^k IMinds Future Health Department   (Belgium)

more..

Author keywords

logistic models; ovarian neoplasms; sensitivity and specificity; ultrasonography

Indexed keywords

CA 125 ANTIGEN;

ADNEXA DISEASE; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CYST; DIFFERENTIAL DIAGNOSIS; EVALUATION; FEMALE; HUMAN; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; OVARY TUMOR; PATHOLOGY; PREOPERATIVE CARE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; VERY ELDERLY;

ADNEXAL DISEASES; ADULT; AGED; AGED, 80 AND OVER; CA-125 ANTIGEN; CYSTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84876674918     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.12294     Document Type: Article

References (27)

1. Jain KA,. Prospective evaluation of adnexal masses with endovaginal gray-scale and duplex and color Doppler US: correlation with pathologic findings. Radiology 1994; 191: 63-67. (Pubitemid 24098202)
2. Valentin L., Prospective cross-validation of Doppler ultrasound examination and gray-scale ultrasound imaging for discrimination of benign and malignant pelvic masses. Ultrasound Obstet Gynecol 1999; 14: 273-283.
3. Valentin L, Hagen B, Tingulstad S, Eik-Nes S,. Comparison of 'pattern recognition' and logistic regression models for discrimination between benign and malignant pelvic masses: a prospective cross validation. Ultrasound Obstet Gynecol 2001; 18: 357-365. (Pubitemid 32947204)
4. Valentin L., Pattern recognition of pelvic masses by gray-scale ultrasound imaging: the contribution of Doppler ultrasound. Ultrasound Obstet Gynecol 1999; 14: 338-347. (Pubitemid 30032358)
5. Sokalska A, Timmerman D, Testa AC, Van Holsbeke C, Lissoni AA, Leone FP, Jurkovic D, Valentin L,. Diagnostic accuracy of transvaginal ultrasound examination for assigning a specific diagnosis to adnexal masses. Ultrasound Obstet Gynecol 2009; 34: 462-470.
6. Valentin L., Use of morphology to characterize and manage common adnexal masses. Best Pract Res Clin Obstet Gynaecol 2004; 18: 71-89. (Pubitemid 38324637)
7. Valentin L, Ameye L, Jurkovic D, Metzger U, Lecuru F, Van Huffel S, Timmerman D,. Which extrauterine pelvic masses are difficult to correctly classify as benign or malignant on the basis of ultrasound findings and is there a way of making a correct diagnosis? Ultrasound Obstet Gynecol 2006; 27: 438-444. (Pubitemid 43735485)
8. Valentin L, Ameye L, Savelli L, Fruscio R, Leone FP, Czekierdowski A, Lissoni AA, Fischerova D, Guerriero S, Van Holsbeke C, Van Huffel S, Timmerman D,. Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help. Ultrasound Obstet Gynecol 2011; 38: 456-465.
9. Jacobs I, Oram D, Fairbanks J, Turner J, Frost C, Grudzinskas JG,. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol 1990; 97: 922-929. (Pubitemid 20340625)
10. Timmerman D, Testa AC, Bourne T, Ferrazzi E, Ameye L, Konstantinovic ML, Van Calster B, Collins WP, Vergote I, Van Huffel S, Valentin L,. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group. J Clin Oncol 2005; 23: 8794-8801. (Pubitemid 46211525)
11. Van Holsbeke C, Van Calster B, Testa AC, Domali E, Lu C, Van Huffel S, Valentin L, Timmerman D,. Prospective internal validation of mathematical models to predict malignancy in adnexal masses: results from the international ovarian tumor analysis study. Clin Cancer Res 2009; 15: 684-691.
12. Timmerman D, Van Calster B, Testa AC, Guerriero S, Fischerova D, Lissoni AA, Van Holsbeke C, Fruscio R, Czekierdowski A, Jurkovic D, Savelli L, Vergote I, Bourne T, Van Huffel S, Valentin L,. Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: a temporal and external validation study by the IOTA group. Ultrasound Obstet Gynecol 2010; 36: 226-234.
13. Timmerman D, Valentin L, Bourne TH, Collins WP, Verrelst H, Vergote I,. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group. Ultrasound Obstet Gynecol 2000; 16: 500-505. (Pubitemid 32158133)
14. Kenemans P, van Kamp GJ, Oehr P, Verstraeten RA,. Heterologous double-determinant immunoradiometric assay CA 125 II: reliable second-generation immunoassay for determining CA 125 in serum. Clin Chem 1993; 39: 2509-2513.
15. Heintz AP, Odicino F, Maisonneuve P, Beller U, Benedet JL, Creasman WT, Ngan HY, Pecorelli S,. Carcinoma of the ovary. Int J Gynaecol Obstet 2003; 83 Suppl 1: 135-166. (Pubitemid 39658498)
16. DeLong ER, DeLong DM, Clarke-Pearson DL,. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-845.
17. Hassen K, Ghossain MA, Rousset P, Sciot C, Hugol D, Baddoura R, Vadrot D, Buy JN,. Characterization of papillary projections in benign versus borderline and malignant ovarian masses on conventional and color Doppler ultrasound. AJR Am J Roentgenol 2011; 196: 1444-1449.
18. Carley ME, Klingele CJ, Gebhart JB, Webb MJ, Wilson TO,. Laparoscopy versus laparotomy in the management of benign unilateral adnexal masses. J Am Assoc Gynecol Laparosc 2002; 9: 321-326.
19. Medeiros LR, Fachel JM, Garry R, Stein AT, Furness S,. Laparoscopy versus laparotomy for benign ovarian tumours. Cochrane Database Syst Rev 2005: CD004751.
20. Cannistra SA,. Cancer of the ovary. N Engl J Med 2004; 351: 2519-2529.
21. Vergote I, De Brabanter J, Fyles A, Bertelsen K, Einhorn N, Sevelda P, Gore ME, Kaern J, Verrelst H, Sjovall K, Timmerman D, Vandewalle J, Van Gramberen M, Trope CG,. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 2001; 357: 176-182. (Pubitemid 32108089)
22. Morice P., Borderline tumours of the ovary and fertility. Eur J Cancer 2006; 42: 149-158. (Pubitemid 43083483)
23. Testa AC, Timmerman D, Van Belle V, Fruscella E, Van Holsbeke C, Savelli L, Ferrazzi E, Leone FP, Marret H, Tranquart F, Exacoustos C, Nazzaro G, Bokor D, Magri F, Van Huffel S, Ferrandina G, Valentin L,. Intravenous contrast ultrasound examination using contrast-tuned imaging (CnTI) and the contrast medium SonoVue for discrimination between benign and malignant adnexal masses with solid components. Ultrasound Obstet Gynecol 2009; 34: 699-710.
24. Sladkevicius P, Jokubkiene L, Valentin L,. Contribution of morphological assessment of the vessel tree by three-dimensional ultrasound to a correct diagnosis of malignancy in ovarian masses. Ultrasound Obstet Gynecol 2007; 30: 874-882. (Pubitemid 350205409)
25. Van Gorp T, Cadron I, Vergote I,. The utility of proteomics in gynecologic cancers. Curr Opin Obstet Gynecol 2011; 23: 3-7.
26. Palmer C, Duan X, Hawley S, Scholler N, Thorpe JD, Sahota RA, Wong MQ, Wray A, Bergan LA, Drescher CW, McIntosh MW, Brown PO, Nelson BH, Urban N,. Systematic evaluation of candidate blood markers for detecting ovarian cancer. PLoS One 2008; 3: e2633.
27. Teschendorff AE, Menon U, Gentry-Maharaj A, Ramus SJ, Gayther SA, Apostolidou S, Jones A, Lechner M, Beck S, Jacobs IJ, Widschwendter M,. An epigenetic signature in peripheral blood predicts active ovarian cancer. PLoS One 2009; 4: e8274.